Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vector
- 1 January 2002
- journal article
- research article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 9 (1), 2-11
- https://doi.org/10.1038/sj.gt.3301616
Abstract
We have utilized a recombinant adeno-associated viral (AAV) vector carrying the angiostatin gene as an anti-angiogenesis strategy to treat the malignant brain tumor in a C6 glioma/Wistar rat model. Angiostatin, as a potent angiogenesis inhibitor, shows high promises as an anti-cancer drug through the inhibition of tumor neovessel formation. However, sustained in vivo protein delivery is required to achieve the therapeutic effects. The AAV vector has been proven to be able to deliver sustained and high-level gene expression in vivo, and therefore, is well suited to such a purpose. In this study, we implanted 5 × 105 C6 glioma cells into the rat brain 7 days before gene therapy. Intratumoral injection of a high-titer AAV-angiostatin vector has rendered efficacious tumor suppression and resulted in long-term survival in 40% of the treated rats, whereas the control AAV-GFP vector did not have any therapeutic benefits. In addition, we have investigated the combined gene therapy of an adenoviral vector carrying the suicidal thymidine kinase gene along with the AAV-angiostatin vector. The combined therapy offered the best tumor-suppressive effects and increased long-term survival to 55% in the treated rats. Our study has demonstrated the potential of using AAV as a safe and effective vector for anti-angiogenic gene therapy of brain tumors.Keywords
This publication has 35 references indexed in Scilit:
- Tumor angiogenesis - a new therapeutic target in gliomasActa Neurologica Scandinavica, 2009
- Multi-modal combination gene therapy for malignant glioma using replication-defective HSV vectorsDrug Discovery Today, 2001
- HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcomaGene Therapy, 2000
- Effective Treatment of Experimental Glioblastoma by HSV Vector-Mediated TNFα and HSV-tk Gene Transfer in Combination with Radiosurgery and Ganciclovir AdministrationMolecular Therapy, 2000
- Connexin 43-Enhanced Suicide Gene Therapy Using Herpesviral VectorsMolecular Therapy, 2000
- Adenovirus-mediated p53 Gene Therapy for Human GliomasNeurosurgery, 1999
- Deletion of multiple immediate–early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neuronsGene Therapy, 1998
- New perspectives in clinical oncology from angiogenesis researchEuropean Journal Of Cancer, 1996
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990